BlueCrest Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,415
Closed -$202K 1154
2017
Q1
$202K Buy
+4,415
New +$220K 0.01% 628

Other funds holding SYNH

BlueCrest Capital Management's SYNH Position: Q2 2017 in Review

BlueCrest Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 4,415 shares — an estimated $202K sold.

BlueCrest Capital Management first reported a position in SYNH in Q1 2017 and held it in 1 quarter. The position peaked at $202K in Q1 2017. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • BlueCrest Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,415 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $202K.
  • BlueCrest Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 1 quarter.
  • BlueCrest Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $202K in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on BlueCrest Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.